文献速递头颈部肿瘤放疗姑息放疗与转移瘤

高压氧治疗头颈癌放疗后晚期组织毒性损伤的系统综述

Hyperbaric oxygen therapy for late radiation tissue toxicity injury after head and neck cancer: a systematic review of the literature.
PubMed 文献 · Radiat Oncol · 2025-10-03

该系统综述检索了PubMed、Embase和Cochrane Library(截至2024年8月12日),纳入17项研究共640例接受高压氧治疗的头颈癌放疗后晚期组织毒性损伤患者;14项研究报告了积极结果,11项研究具有显著P值,不良事件发生率低,但证据质量主要较低。

要点

  • HBOT对头颈癌放疗后晚期组织毒性损伤可能有效,14/17项研究报告积极结果。
  • 涉及ORN和口腔健康的研究几乎均报告有益效果,多项具有显著P值。
  • 证据主要来自低质量、高偏倚风险、样本量有限且结局指标不一致的研究。

核心结论

  • 本综述提示HBOT可能对头颈癌患者放疗后晚期组织毒性损伤有效。
  • 支持证据主要来自低质量研究,存在高偏倚风险、样本量有限和结局指标不一致的问题。
  • 需要更多高质量研究来明确HBOT的真实临床获益和最佳使用方式。

研究设计与样本

  • 系统综述,检索PubMed、Embase和Cochrane Library于2024年8月12日进行,纳入2004年至2022年发表的研究。
  • 纳入接受HBOT治疗的头颈癌伴晚期组织毒性损伤患者的研究,共17项研究、640例患者。
  • 使用Joanna Briggs Institute(JBI)清单进行批判性评价,提取患者特征、HBOT治疗细节和主要结局数据。
  • 主要结局评估临床变化(如Notani评分),次要结局关注患者报告指标如VAS和OHIP。
  • 采用描述性分析并结合统计指标解释结果。

主要发现

  • 17项研究中14项报告HBOT治疗头颈癌放疗后晚期组织毒性损伤的积极结果。
  • 几乎所有研究ORN和口腔健康的研究均报告有益效果,多项具有显著P值。
  • 总体11项研究具有显著P值,各研究报告的不良事件发生率低。

关键数值与推荐

  • 原文未报告具体的Notani评分变化数值、VAS或OHIP的量化结果及具体P值。

临床怎么用

  • HBOT可作为头颈癌放疗后晚期组织毒性损伤(如ORN和伤口愈合不良)的一种治疗选择,但需结合低质量证据的背景谨慎决策。
  • 临床应用中应关注不良事件,原文报告不良事件发生率低。

局限性

  • 支持证据主要来自低质量研究,存在高偏倚风险。
  • 纳入研究样本量有限。
  • 结局指标不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Head and neck cancer (HNC), most of which are squamous cell carcinomas, is the seventh most common cancer worldwide. Radiotherapy is a standard treatment for HNC but may lead to late complications and severe complications like osteoradionecrosis (ORN) and impaired wound healing due to tissue hypoxia. Hyperbaric oxygen therapy (HBOT) has shown promise in ameliorating these late radiation effects. The purpose of this review is to summarize the extent of the literature on the effectiveness of HBOT in the treatment of late radiation tissue toxicity injuries (LRTTI) specifically in HNC patients. METHODS/MATERIAL AND METHODS: A systematic literature search was performed using PubMed, Embase, and the Cochrane Library on August 12, 2024, including studies published between 2004 and 2022. Studies that included HNC patients with LRTTI and treated with HBOT were selected. Articles were critically appraised using the Joanna Briggs Institute (JBI) checklists. Data on patient characteristics, HBOT treatment details, and main outcomes were extracted. Primary outcomes assessed included clinical changes, such as the Notani score, while secondary outcomes focused on patient-reported measures such as VAS and OHIP. Descriptive analysis, supported by statistical measures, was used to interpret the results. RESULTS: A total of 17 studies were reviewed, including 640 HNC patients with LRTTI who were treated with HBOT. In this systematic review, HBOT is presented in the included studies as a reliable and safe treatment for the treatment of LRTTI in HNC patients, with positive outcomes observed in 14 out of 17 studies. Specifically, almost all studies investigating ORN and oral health reported beneficial effects, with significant p-values in multiple cases. Overall, significant p-values were found in 11 studies, with a low incidence of adverse effects reported across the studies. CONCLUSION: This review suggests that HBOT may be effective in the treatment of LRTTI in HNC patients. However, the supporting evidence is mainly derived from low quality studies with a high risk of bias, limited sample sizes, and inconsistent outcome measures. Additional high quality studies are needed to clarify the true clinical benefits and optimal use of HBOT.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. El Hadji S, Teguh DN, Ridderikhof ML, et al. Hyperbaric oxygen therapy for late radiation tissue toxicity injury after head and neck cancer: a systematic review of the literature. Radiat Oncol. 2025. PMID: 41044659. doi:10.1186/s13014-025-02680-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。